What is the most recent earnings date for TYRA stock?
TYRA BIOSCIENCES INC (TYRA) last reported earnings on 3/2/2026.
NASDAQ:TYRA • US90240B1061
Past quarterly earnings results for TYRA BIOSCIENCES INC (TYRA), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.57 | -0.54 | -5.80% | -32.56% | - | - | ||
| Q3 2025 | -0.50 | -0.51 | 1.47% | -21.95% | - | - | ||
| Q2 2025 | -0.47 | -0.54 | 12.85% | -46.87% | - | - | ||
| Q1 2025 | -0.47 | -0.50 | 5.89% | -34.29% | - | - | ||
| Q4 2024 | -0.43 | -0.49 | 12.26% | 18.87% | - | - | ||
| Q3 2024 | -0.41 | -0.41 | -0.82% | 16.33% | - | - | ||
| Q2 2024 | -0.32 | -0.42 | 23.17% | -3.23% | - | - | ||
| Q1 2024 | -0.35 | -0.46 | 24.61% | -25.00% | - | - | ||
| Q4 2023 | -0.53 | -0.49 | -8.10% | -70.97% | - | - | ||
| Q3 2023 | -0.49 | -0.36 | -36.22% | -63.33% | - | - | ||
| Q2 2023 | -0.31 | -0.35 | 11.57% | 13.89% | - | - | ||
| Q1 2023 | -0.28 | -0.37 | 25.00% | 22.22% | - | - | ||
| Q4 2022 | -0.31 | -0.37 | 15.58% | -29.17% | - | - | ||
| Q3 2022 | -0.30 | -0.42 | 27.82% | 58.33% | - | - | ||
| Q2 2022 | -0.36 | -0.32 | -11.45% | - | - | - | ||
| Q1 2022 | -0.36 | -0.20 | -76.47% | - | - | - | ||
| Q4 2021 | -0.24 | -0.21 | -12.04% | - | - | - | ||
| Q3 2021 | -0.72 | -0.30 | -143.41% | - | - | - | ||
| Q2 2021 | - | - | - | - | ||||
| Q1 2021 | - | - | - | - | ||||
| Q4 2020 | - | - | - | - | ||||
| Q3 2020 | - | - | - | - | ||||
| Q2 2020 | - | - | - | - | ||||
| Q1 2020 | - | - | - | - |
Notes
TYRA BIOSCIENCES INC (TYRA) last reported earnings on 3/2/2026.
TYRA BIOSCIENCES INC (TYRA) missed EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, TYRA BIOSCIENCES INC (TYRA) has beaten EPS estimates in 3 out of 4 releases.